Stay updated with breaking news from Peter Maag. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Lazard Asset Management LLC raised its position in CareDx, Inc (NASDAQ:CDNA – Get Rating) by 46.3% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 7,738 shares of the company’s stock after purchasing an additional 2,448 shares during the quarter. Lazard Asset Management LLC’s holdings […]
Renaissance Technologies LLC decreased its position in CareDx, Inc (NASDAQ:CDNA – Get Rating) by 21.5% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 760,400 shares of the company’s stock after selling 207,800 shares during the quarter. Renaissance Technologies […]
Guggenheim Capital LLC trimmed its position in CareDx, Inc (NASDAQ:CDNA – Get Rating) by 1.8% during the 3rd quarter, according to its most recent Form 13F filing with the SEC. The fund owned 102,556 shares of the company’s stock after selling 1,913 shares during the period. Guggenheim Capital LLC owned about 0.19% of CareDx worth […]
/PRNewswire/ -- Kyverna Therapeutics ("Kyverna"), a cell therapy company with the mission of engineering a new class of therapies for serious autoimmune...
CareDx, Inc (NASDAQ:CDNA – Get Rating) has been given a consensus recommendation of “Buy” by the seven research firms that are presently covering the firm, MarketBeat reports. One investment analyst has rated the stock with a sell rating, two have issued a buy rating and one has assigned a strong buy rating to the company. […]